Sex Disparity in Gastric Cancer: Female Sex is a Poor Prognostic Factor for Advanced Gastric Cancer
- 28 July 2016
- journal article
- research article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 23 (13) , 4344-4351
Abstract
The overall incidence of gastric cancer (GC) is higher in males than females. Specifically, signet ring cell carcinoma (SRC) is more frequently observed in younger female patients. However, limited information focused on sex-specific differences in GC has been reported. The aim of our study was to analyze clinicopathological differences between sex groups to reveal sex disparities in GC. We retrospectively analyzed 4722 patients with GC who underwent gastrectomy (females: 1586 (33.6 %); males: 3136 (66.4 %), and analyzed clinicopathological features between these sex groups. The overall survival (OS) rate was investigated between the two sex groups, with special reference to the pathologic World Health Organization GC classifications. Immunohistochemistry staining of sex hormone receptors, including the estrogen receptor (ER)-alpha, ER-beta, progesterone receptor, and androgen receptor, was performed according to sex and pathological classification. Female patients were significantly associated with a younger age, poorly differentiated adenocarcinoma, and SRC compared with males. Female patients showed a significantly poorer OS than male patients, especially among those with advanced GC (AGC) aged aecurrency sign45 years. In females with AGC, those with SRC had a significantly poorer OS than those with other histologies. Moreover, the expression of ER-beta was different between females and males with SRC. Females with GC were significantly younger and had a different SRC histology compared with males. Furthermore, females had significantly poorer prognostic factors among young patients with SRC. Thus, young female GC patients with SRC are a main target group in which to improve prognosis.Keywords
This publication has 28 references indexed in Scilit:
- Expression profile and prognostic role of sex hormone receptors in gastric cancerBMC Cancer, 2012
- Sex Hormones, Hormonal Interventions, and Gastric Cancer Risk: A Meta-analysisCancer Epidemiology, Biomarkers & Prevention, 2012
- Reproductive factors and risk of oesophageal and gastric cancer in the Million Women Study cohortBritish Journal of Cancer, 2011
- Clinicopathological Features and Surgical Treatment of Gastric Cancer in South Korea: The Results of 2009 Nationwide Survey on Surgically Treated Gastric Cancer PatientsJournal of Gastric Cancer, 2011
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trialThe Lancet, 2010
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast CancerJournal of Oncology Practice, 2010
- Menstrual and reproductive factors and gastric cancer risk in a large prospective study of womenGut, 2007
- Body mass, tobacco and alcohol and risk of esophageal, gastric cardia, and gastric non-cardia adenocarcinoma among men and women in a nested case-control studyCancer Causes & Control, 2005
- Delayed rise in incidence of gastric cancer in females results in unique sex ratio (M/F) pattern: etiologic hypothesisGastric Cancer, 2002
- Clinicopathologic comparisons between estrogen receptor‐positive and ‐negative gastric cancersJournal of Surgical Oncology, 1992